• Management pregnance on the background of retrochoric hematoma in the I trimester of pregnancy (Literature review)

Management pregnance on the background of retrochoric hematoma in the I trimester of pregnancy (Literature review)

HEALTH OF WOMAN. 2018.9(135):118–124; doi 10.15574/HW.2018.135.118

Romanenko T. G., Zhaloba G. M., Staselovych L.Y., Voronina K. I.
Shupyk National Medical Academy of Postgraduate Education MH of Ukraine, Kiev, Kiev

In modern obstetrical and gynecological practice, the problem of miscarriage, one of the manifestations of which is the retrochoric hematoma, does not lose its relevance. Despite numerous studies of the etiology and pathogenesis of this problem, there are still many questions that need answers.

The purpose of this systematic review was to highlight the problem of retrochoric hematomas, the etiological features of their occurrence and the importance of treatment in order to avoid the development of further complications, the preservation and prolongation of pregnancy. The features of diagnostics and subsequent therapy with the main pathogenetically grounded drug, micronized progesterone, are considered, which provides early support for pregnancy and a reduction in the frequency of obstetric and perinatal complications that combine into large obstetrical syndromes.

Analyzed data from modern world studies suggest that it is progestins (micronized progesterone) that should be the drug of choice in the treatment of miscarriage, which occurs against the background of retrochorial hematoma. The conclusion of the expert group of ESHRE on special issues of early pregnancy is: in women with bleeding in early pregnancy and the formation of retrochoric and retrocopental hematomas the risk of premature birth, the development of fetal growth retardation syndrome, placental abruption in the 2nd and 3rd trimesters is increased. In order to prevent preterm delivery experts recommend prolongation of therapy with micronized progesterone (200 mg per day intravaginally from early pregnancy).

In the diagnostics of retrochoric hematoma the tactics of management should be based on the therapy of preserving pregnancy and preventing its further complications. The high efficacy of micronized progesterone Utrozhestan and haemostatic therapy in the treatment of abortion complicated by retrochoric hematoma allows prolonging pregnancy and achieving favorable perinatal outcomes. The absence of side effects and good tolerance extend the possibilities of using Utrozhestan by women with retrochoric hematoma in case of a threat of termination of pregnancy.

Key words: retrochorial hematoma, miscarriage, micronized progesterone, large obstetrical syndromes, Utrozhestan.

REFERENCES

1. Zhabitska LA. (2007). Novi aspekty patohenezu nevynoshuvannia vahitnosti, likuvannia ta profilaktyka. Dys. kand. med. nauk: 14.01.01. Natsionalnyi medychnyi un-t im. O.O. Bohomoltsia. K:169.

2. Solovova LD. (2014). Kompleksnyiy podhod k lecheniyu ugrozhayuschego preryivaniya beremennosti s retrohorialnyimi gematomami. Diss. kand. med. nauk: 14.01.01. Mesto zaschityi: Samarskiy gosudarstvennyiy meditsinskiy universitet. Samara:190.

3. Soldo V, Cutura N, Zamurovic M. (2013). Threatened miscarriage in the first trimester and retrochohematomas: sonographic evaluation and significance. Clin Exp Obstet Gynecol 40.4:548–50. PMid:24597253

4. Xiang L, Wei Z, Cao Y. (2014). Symptoms of an Intrauterine Hematoma Associated with Pregnancy Complications: A Systematic Review. PLoS ONE 9.11:e111676.

5. Agarkova IA. (2013). Profilaktika poteri beremennosti rannih srokov u zhenschin s nerazvivayuscheysya beremennostyu. Avtoref. diss. kand. med. nauk. Samara:27.

6. Saveleva GM i dr. (2008). Akusherstvo: uchebnik. M, GEOTAR-Media.

7. Nagy S, Bush M, Stone J et al. (2005). Clinical significance of subchorionic and retroplacental hematomas detected in the first trimester of pregnancy. Orv Hetil 146.42:2157–61. PMid:16315997

8. Nagy S, Bush M, Stone J et al. (2003). Clinical Significance of Subchorionic and Retroplacental Hematomas Detected in the First Trimester of Pregnancy. Obstet Gynecol 102:94–100. https://doi.org/10.1097/00006250-200307000-00019; https://doi.org/10.1016/S0029-7844(03)00403-4

9. Pelinescu-Onciul D. (2007). Subchorionic hemorrhage treatment with dydrogesterone. Gynecol Endocrinol 23 Suppl. 1:77–81. https://doi.org/10.1080/09513590701584741; PMid:17943544

10. Asato K, Mekaru K, Heshiki C et al. (2014). Subchorionic hematoma occurs more frequently in in vitro fertilization pregnancy. Eur J Obstet Gynecol Reprod Biol 181:41–44. https://doi.org/10.1016/j.ejogrb.2014.07.014; PMid:25126980

11. Ignatko IV, Martirosyan NT. (2007). Prognoz perinatalnyih ishodov u zhenschin s ugrozoy preryivaniya beremennosti i chastichnoy otsloykoy horiona v pervom trimestre. Materialyi IH Vserossiyskogo nauchnogo foruma «Mat i ditya». M:88–89.

12. Kyser KL. (2012). Meta-analysis of subchorionic hemorrhage and adverse pregnancy outcomes. Proceedings in obstetrics and gynecology 2.4.

13. Saraswat L, Bhattacharya S, Maheshwari A, Bhattacharya S. (2010). Maternal and perinatal outcome in women with threatened miscarriage in the first trimester: a systematic review. BJOG 117.3:245–57. https://doi.org/10.1111/j.1471-0528.2009.02427.x

14. Strasburger JF, Wakai RT. (2010). Fetal cardiac arrhythmia detection and in utero therapy. Nature reviews cardiology 7.5:277–90. DOI: 10.1038/nrcardio

15. Crane S, Collins L, Hall J et al. (2012). Reducing utilization by uninsured frequent users of the emergency department: combining case management and drop-in group medical appointments. J Am Board Fam Med 25.2:184–91. https://doi.org/10.3122/jabfm.2012.02.110156; PMid:22403199

16. Asato K, Mekaru K, Heshiki C et al. (2014). Subchorionic hematoma occurs more frequently in in vitro fertilization pregnancy. Eur J Obstet Gynecol Reprod Biol 181:41–4. https://doi.org/10.1016/j.ejogrb.2014.07.014; PMid:25126980

17. Leite J, Ross P, Rossi AC, Jeanty P. (2006). Prognosis of Very Large First-Trimester Hematomas. J Ultrasound in Medicine 25.11:1441–5. https://doi.org/10.7863/jum.2006.25.11.1441

18. Pirogova VI. (2014). Kliniko-paraklinicheskie aspektyi beremennosti, kotoraya oslozhnilas retrohorialnoy gematomoy. Reproduktivnaya endokrinologiya 5(19):108–110.

19. Ferri FF. (2014). Vaginal Bleeding During Pregnancy. In: Ferri’s clinical advisor. Mosby: 1143. e1.

20. Kovaleva YuV. (2013). Retrohorialnaya gematoma. Voprosyi etiopatogeneza, diagnostiki, terapii. Zhurnal akusherstva i zhenskih bolezney LXII;4.

21. Mondoeva SS, Suhanova GA, Podzolkova NM. (2009). Endotelialnaya disfunktsiya – dopolnitelnyiy faktor razvitiya sindroma poteri ploda u patsientok s trombofiliey. Puti korrektsii. Problemyi reproduktsii 6:65–67.

22. Krukier I. (2000). Production of NO and oxidative destruction of proteins in the place during normal pregnancy and placental insufficiency. Bull Exp Biol Ved 136.4:369–371. https://doi.org/10.1023/B:BEBM.0000010954.15992.68

23. McPherson JA, Odibo AO, Shanks AL et al. (2013). Adverse outcomes in twin pregnancies complicated by early vaginal bleeding. Am J Obstet Gynecol 208:56.e1. https://doi.org/10.1016/j.ajog.2012.10.875; PMid:23098666

24. Chhabra A, Lin EC. Subchorionic Hemorrhage Imaging. Medscape.com, Apr 2014. Available from: https://emedicine.medscape.com/article/404971-overview, last accessed Sept 16, 2018.

25. Palatnik A, Grobman WA. (2015). The relationship between first-trimester subchorionic hematoma, cervical length, and preterm birth. Am J Obstet Gynecol 213.3:403.e1-4. https://doi.org/10.1016/j.ajog.2015.05.019; PMid:25981842

26. Tower CL, Regan L. (2001). Intrauterine hematomas in a recurrent miscarriage population. Hum Reprod 16:2005–7. https://doi.org/10.1093/humrep/16.9.2005

27. Seki H et al. (1998). Persistent subchorionic hematoma with clinical symptoms until delivery. Int J Obstet Gynaecol 63:123–8. https://doi.org/10.1016/S0020-7292(98)00153-2

28. Mandruzzato GP et al. (1989). The intrauterine hematoma: diagnostic and clinical aspects. J Ultrasound 17:503–10. https://doi.org/10.1002/jcu.1870170708

29. Kuznetsova NB. (2017). Profilaktika perinatalnyih oslozhneniy u beremennyih s retrohorialnyimi gematomami s uchetom ih patogeneza. Diss. d-ra med. nauk: 14.01.01. Mesto zaschityi: FGU Nauchnyiy tsentr akusherstva, ginekologii i perinatologii im. akademika V.I. Kulakova Ministerstva zdravoohraneniya Rossiyskoy Federatsii.

30. Lvova AG. (2003). Prognozirovanie techeniya beremennosti pri sindrome poteri ploda na osnovanii ehograficheskoy otsenki plodnogo yaytsa i fetoplatsentarnoy gemodinamiki. Avtoref. diss. kand. med. nauk. M:24.

31. Andreeva ES, Stepankova EA. (2012). Osobennosti morfologicheskih izmeneniy platsentyi u patsientok s ugrozoy preryivaniya beremennosti i otsloykoy horiona s obrazovaniem vnutrimatochnoy gematomyi. Vestnik RUDN. Seriya «Meditsina». 5:36–39.

32. Andreeva ES. (20130. Techenie i ishod beremennosti, oslozhnivsheysya otsloykoy horiona. Avtoref. dis. kand. med. nauk. M:20–22.

33. Arzhanova ON, Kosheleva NG. (2004). Etiopatogenez nevyinashivaniya beremennosti. Zhurnal akusherstva i zhenskih bolezney LIII;1:37–41.

34. Ignatko IV. (2005). Beremennost vyisokogo riska perinatalnoy patologii: patogenez platsentarnoy nedostatochnosti, rannyaya diagnostika i akusherskaya taktika. Avtoref. diss. d-ra med. nauk. M:48.

35. Choudhury SR, Knapp LA. (2000). Human reproductive failure I: Immunological factors. Hum Reprod 7.2:113–34.

36. Cole LA. (2010). Biological functions of hCG and hCG-related molecules. Reprod Biol Endocrinol 8:102. https://doi.org/10.1186/1477-7827-8-102; PMid:20735820 PMCid:PMC2936313

37. Granger JP, Alexander BT et al. (2001). Pathophysiology of pregnancy-induced Hypertension. Am J Hypertens 14.6:178S–185S. https://doi.org/10.1016/S0895-7061(01)02086-6

38. Hertelendy F, Zakar T. (2004). Regulation of myometrial smooth muscle functions. Curr Pharm Des 10.20:2499–517. https://doi.org/10.2174/1381612043383926

39. Gerald J et al. (2007). Physiology of Alpha-Fetoprotein as a Biomarker for Perinatal. Distress: Relevance to Adverse Pregnancy Outcome. Exp Biol Med 232:993–1004. https://doi.org/10.3181/0612-MR-291; PMid:17720945

40. Murashko LE, Klimenchenko NI. (2010). Opyit primeneniya mikronizirovannogo progesterona v pervoy polovine beremennosti. Akusherstvo i ginekologiya 5–6:58–59.

41. Zyigmunt M, Sapa Ya. (2017). Progesteron – novyiy vzglyad na davno izvestnoe lekarstvo. Obzor literaturyi. Reproduktivnaya endokrinologiya 1(33):17–25.

42. Volkova EV, Gaydamakina LF, Demidova AI i dr. (2016). Techenie beremennosti, oslozhnennoe retrohorialnoy gematomoy v pervom trimestre. Farmateka. 12 (325).